مجله اخلاق زیستی- علمی پژوهشی

Qare Yazi B. Risk assessment of foods resulting from genetic engineering, Tehran: Biosafety Association Publications; 2017. p.137. [Persian]

Rastgoo L, Alemzade A. The position of transgenic plants in sustainable agriculture: Past, present and future. Journal of Biosafety Society of Iran. 2008; 1(1): 16-36. [Persian]

Fontes EM. Legal and regulatory concerns about transgenic plants in Brazil. Journal of Invertebrate Pathology. 2003; 83(2): 100-103.

OECD (Organisation for Economic Co-operation and Development). Biotechnology Regulatory Developments in OECD Member countries. Paris. 2003. Available at: https://www.oecd.org/oecd/pages/hom.

Kinderlerer J. The Cartagena protocol on biosafety. Collection of Biosafety Reviews. 2008; 4(s 12): 16-65.

Lusser M, Parisi C, Plan D, Rodriguez-Cerez E. New plant breeding techniques. Luxembourg: Publications Office of the European Union; 2011.

Spök A, Hofer H, Lehner P, Valenta R, Stirn S, Gaugitsch H. Risk assessment of GMO products in the European Union. Vienna: Bundesministerium für Gesundheit und Frauen; 2004.

Hoffmann-Sommergruber K. Medical issues related to genetically modified plants of relevance to Switzerland. Zurich: vdf Hochschulverlag AG; 2012.

Jabbaran MM. Convergence of bioethics principles in the field of research with Islamic approach. Quarterly Journal of Ethics. 2018; 11(41): 89-106. [Persian]

Rahnama H. Bioethics and transgenic products. Journal of Ethics in Science and Technology, 2008; 1(2): 1-14.

Rahnama H. An attitude on the aspects of bioethics in genetic engineering. Special issue of the 12th Iranian Genetics Congress; 2012. p.1-3.

Kok EJ, van Dijk JP, Prins TW, Kleter GA. Safety assessment of GMO-derived foods. Collect Biosaf Rev. 2010; 5: 82-111.

Wolfenbarger LL. Proceedings of a Workshop on Criteria for Field Testing of Plants with Engineered Regulatory, Metabolic and Signaling Pathways, June 3-4, 2002, Washington, DC. In Workshop on Criteria for Field Testing of Plants with Engineered Regulatory, Metabolic, and Signaling Pathways. Information Systems for Biotechnology; 2002.

Biotechnology MF. Human Health and Development: An Evidence-based Study. Geneva: World Health Organization; 2005. p.53.

Atici C. Low levels of genetically modified crops in international food and feed trade: FAO International Survey and Economic Analysis. FAO Commodity and Trade Policy Research Working Papers; 2014. No.44.

Genetically Modified Food & Feed-Labeling, Food Safety- from the Farm to the Fork. Available at: https://www.ec.europa.eu.food.food.biotechnology.gmfood.labelling_en.htm.

Mahdizadeh M, Rabiei M, Alebooye M, Rastgar H. "GMO" food labeling and consumer rights. Scientific Research Journal of Medical Law. 2011; 5(16): 115-129. [Persian]

Adcock M. EU Legislation on Genetically Modified Organisms. EU GMO Legislation; 2006.

Carter CA, Gruère GP. Mandatory labeling of genetically modified foods: Does it really provide consumer choice?. Ag Bio Forum. 2003; 6(1&2): 68-70.

Boemer MR, Sampaio MA. The Exercise of nursing in bioethical dimension. Rev Lat Am Enfermagem. 1997; 5(2): 33-38.

Beauchamp TL, Childress J. Principles of Biomedical Ethics. 7th ed. USA: Oxford University Press; 2013.

Asadi Vanani SR, Mohseni Dehkalani M, Ebrahimi S, Soltani A. The Legitimacy of Hypnosis and its Consistency with Principles of Bioethics. Bioethics Journal. 2018; 8(30): 107-117. [Persian]

Larijani B. Physician and Ethical Considerations. 1st ed. Tehran: Nashr Frada; 2002. p.76. [Persian]

Francioni F. Genetic resources, biotechnology and human rights: The international legal framework. European University Institute Law Working Paper. 2006 Oct (2006/17).